Clinica Universidad de Navarra Madrid; Servicio de Oncología

Madrid 28027

0 studies enrolling now · 5 studies all time

What they study most

Advanced/Metastatic Head and Neck, Oesophageal and Cervical Cancers, Biliary Tract Cancer, Breast Cancer, Carcinoma, Hepatocellular, Cutaneous Melanoma, Liver Metastases, Mucosal Melanoma, OVARIAN CANCER, Secondary Liver Cancer, Uveal Melanoma

Studies at this site

• A Study Evaluating Safety, Pharmacokinetics, Pharmacodynamics, And Clinical Activity Of RO7119929 (TLR7 Agonist) In Participants With Unresectable Advanced Or Metastatic Hepatocellular Carcinoma, Biliary Tract Cancer, Or Solid Tumors With Hepatic Metastases — Completed
• A Study To Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer — Completed
• A Clinical Study of Cobimetinib Administered in Combination With Niraparib, With or Without Atezolizumab to Patients With Advanced Platinum-sensitive Ovarian Cancer — Completed
• Basket Study to Evaluate the Therapeutic Activity of Simlukafusp Alfa as a Combination Therapy in Participants With Advanced and/or Metastatic Solid Tumors — Stopped early
• A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas — Completed